Clinical Trials
Roche reports promising Phase II results with new targeted...
Roche announced results from a Phase II clinical study of RG7204 PLX4032), an investigational first-in-class molecule designed to selectively inhibit a cancer-causing, mutated form of...
Clinical Trials
Genzyme Announces Results of Phase 3 Trial of Clolar...
Genzyme Corporation announced results today from its CLASSIC I phase 3 trial comparing Clolar® (clofarabine) in combination with the chemotherapy agent cytarabine (ara-c) to cytarabine...
Clinical Trials
Boehringer Ingelheim announced approval for TWYNSTA®. TWYNSTA single pill...
Boehringer Ingelheim announced today that the European Commission confirmed the positive opinion of the European Medicines Agency (EMA) approving TWYNSTA®. TWYNSTA® is indicated for the...
Clinical Trials
Amgen announced that results from the PRIME ‘203’ and...
Amgen announced that results from the PRIME '203' and '181' pivotal Phase 3 trials evaluating Vectibix(R) (panitumumab) in combination with chemotherapy (FOLFOX or FOLFIRI) as...
Clinical Trials
Bristol-Myers Squibb announced results from a randomized, double-blind Phase...
Bristol-Myers Squibb Company and AstraZeneca announced results from a randomized, double-blind Phase 3 clinical study in adults with type 2 diabetes inadequately controlled on metformin...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.